Table 3 The timing of antiviral therapy and length of stay among children admitted with seasonal influenza (2007-2009) and novel H1N1 influenza (nH1N1)
From: Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients
Seasonal influenza LOS† | nH1N1 influenza LOS† | p-value | |
|---|---|---|---|
No antiviral therapy | 7.2 days (n = 92) | 3.6 days (n = 27) | < .01 |
Antiviral therapy | 6.7 days (n = 37) | 4.4 days (n = 106) | .03 |
Antiviral therapy ≥48 hours after symptom onset or no antiviral therapy | 7.2 days (n = 120) | 4.5 days (n = 82) | < .01 |
Antiviral therapy ≤48 hours of symptom onset | 5.6 days (n = 12) | 3.7 days (n = 51) | .11 |